These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 7349818

  • 1. Benign breast disease: estriol proportions and family history of breast cancer.
    Vakil DV, Morgan RW, Elinson L.
    Cancer Detect Prev; 1981; 4(1-4):517-23. PubMed ID: 7349818
    [Abstract] [Full Text] [Related]

  • 2. Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens.
    Ernster VL, Wrensch MR, Petrakis NL, King EB, Miike R, Murai J, Goodson WH, Siiteri PK.
    J Natl Cancer Inst; 1987 Nov; 79(5):949-60. PubMed ID: 3479643
    [Abstract] [Full Text] [Related]

  • 3. Socioeconomic status, urine estrogens, and breast cancer risk.
    Trichopoulos D, MacMahon B, Brown J.
    J Natl Cancer Inst; 1980 Apr; 64(4):753-5. PubMed ID: 6928988
    [Abstract] [Full Text] [Related]

  • 4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Apr; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 5. Plasma hormone profiles of young women at risk for familial breast cancer.
    Fishman J, Fukushima D, O'Connor J, Rosenfeld RS, Lynch HT, Lynch JF, Guirgis H, Maloney K.
    Cancer Res; 1978 Nov; 38(11 Pt 2):4006-11. PubMed ID: 698948
    [Abstract] [Full Text] [Related]

  • 6. Estrogen profiles of premenopausal women with breast cancer.
    Cole P, Cramer D, Yen S, Paffenbarger R, MacMahon B, Brown J.
    Cancer Res; 1978 Mar; 38(3):745-8. PubMed ID: 626978
    [Abstract] [Full Text] [Related]

  • 7. Estrogen profiles in young women: effect of maternal history of breast cancer.
    Morgan RW, Vakil DV, Brown JB, Elinson L.
    J Natl Cancer Inst; 1978 May; 60(5):965-7. PubMed ID: 642038
    [Abstract] [Full Text] [Related]

  • 8. Abnormal estrogen conjugation in women at risk for familial breast cancer at the periovulatory stage of the menstrual cycle.
    Fishman J, Bradlow HL, Fukushima DK, O'Connor J, Rosenfeld RS, Graepel GJ, Elston R, Lynch H.
    Cancer Res; 1983 Apr; 43(4):1884-90. PubMed ID: 6831424
    [Abstract] [Full Text] [Related]

  • 9. Development of competitive ELISAs for 17beta-estradiol and 17beta-estradiol +estrone+estriol using rabbit polyclonal antibodies.
    Caron E, Sheedy C, Farenhorst A.
    J Environ Sci Health B; 2010 Feb; 45(2):145-51. PubMed ID: 20390944
    [Abstract] [Full Text] [Related]

  • 10. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.
    Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ.
    Cancer; 2006 Sep 15; 107(6):1240-7. PubMed ID: 16902983
    [Abstract] [Full Text] [Related]

  • 11. Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk?
    Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE.
    J Clin Oncol; 2006 Apr 20; 24(12):1823-30. PubMed ID: 16567770
    [Abstract] [Full Text] [Related]

  • 12. Elevated urine estrogen and pregnanediol levels in daughters of breast cancer patients.
    Trichopoulos D, Brown JB, Garas J, Papaioannou A, MacMahon B.
    J Natl Cancer Inst; 1981 Sep 20; 67(3):603-6. PubMed ID: 6944532
    [Abstract] [Full Text] [Related]

  • 13. Cystic disease, family history of breast cancer, and use of oral contraceptives.
    Vakil DV, Elinson L, Morgan RW.
    Cancer Detect Prev; 1981 Sep 20; 4(1-4):511-5. PubMed ID: 7349817
    [Abstract] [Full Text] [Related]

  • 14. Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer.
    Morreal CE, Dao TL, Nemoto T, Lonergan PA.
    J Natl Cancer Inst; 1979 Nov 20; 63(5):1171-4. PubMed ID: 291747
    [Abstract] [Full Text] [Related]

  • 15. [Estrogen: estrone (E1), estradiol (E2), estriol (E3) and estetrol (E4)].
    Shimizu Y.
    Nihon Rinsho; 2010 Jul 20; 68 Suppl 7():448-61. PubMed ID: 20960812
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy).
    Tzingounis V, Cardamakis E, Ginopoulos P, Argiropoulos G.
    Anticancer Res; 1996 Jul 20; 16(6C):3997-4000. PubMed ID: 9042326
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Epidemiology of susceptibility to breast cancer.
    Hulka BS.
    Prog Clin Biol Res; 1996 Jul 20; 395():159-74. PubMed ID: 8895988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.